Examples of GLP-1 Drugs to Know

By GOAL.MD Team — June 8, 2026

Learn examples of GLP-1 drugs, how they differ, who they may fit, and what to expect from physician-supervised weight loss treatment.

If you have been researching medical weight loss, you have probably seen the phrase examples of GLP-1 drugs everywhere – often without much clarity on what actually separates one medication from another. That matters, because these treatments are not interchangeable in every case. The right option depends on your health profile, your goals, how much support you want, and what your prescribing clinician believes is appropriate.

Examples of GLP-1 drugs and what they do

GLP-1 drugs are medications that mimic glucagon-like peptide-1, a hormone involved in blood sugar regulation, appetite signaling, and gastric emptying. In practical terms, they can help people feel fuller sooner, reduce hunger, and support more consistent calorie control. For many adults who have struggled with repeated diet cycles, that can create a more realistic path to sustainable weight loss.

Some of the best-known examples of GLP-1 drugs include semaglutide, liraglutide, and tirzepatide. Not all of these are identical in how they work or how often they are taken. Some are approved for type 2 diabetes, some for chronic weight management, and some may be prescribed based on a broader clinical picture under physician supervision.

That distinction is worth paying attention to. The name of the medication is only part of the story. Dose, indication, side effect profile, cost, access, and treatment plan all influence whether a medication is a strong fit.

Semaglutide

Semaglutide is one of the most recognized GLP-1-based medications in the current weight management space. It is used in different branded forms, depending on the approved indication. In the weight loss conversation, semaglutide is often discussed because it is typically dosed once weekly and has shown meaningful results in many patients when paired with nutrition, behavior change, and medical oversight.

For busy adults, the weekly schedule can be appealing. It reduces the friction of daily dosing and fits well into a physician-supervised telehealth model. At the same time, semaglutide is not a shortcut. It still requires dose titration, monitoring, and realistic expectations around side effects such as nausea, constipation, or reduced appetite that feels stronger than expected.

Liraglutide

Liraglutide is another established GLP-1 medication. Unlike semaglutide, it is generally administered daily rather than weekly. That difference alone can shape patient preference. Some people do well with a daily routine and appreciate the more gradual rhythm, while others want the simplicity of fewer injections.

Liraglutide has been an important option in obesity medicine and diabetes care, and it remains relevant even as newer medications get more attention. In some cases, a clinician may consider it when a patient needs a different tolerability profile or a more tailored approach. Newer is not always automatically better – the best choice is the one that aligns with the individual patient.

Tirzepatide

Tirzepatide is often mentioned alongside GLP-1 medications, although technically it works on more than one hormone pathway. It activates both GIP and GLP-1 receptors, which is part of why it has drawn so much attention in medical weight management. For some patients, that dual-action mechanism may support substantial weight loss under appropriate clinical supervision.

Like semaglutide, tirzepatide is generally taken once weekly. It can be highly effective, but it is not the right fit for everyone. Tolerability, prior medication history, metabolic health, and prescribing eligibility all matter. This is exactly why physician-guided care is valuable – strong results need to be matched with safe, individualized decision-making.

Are all examples of GLP-1 drugs used for weight loss?

No. Some GLP-1 medications were initially developed and approved for type 2 diabetes, while others are specifically indicated for chronic weight management. There is overlap, but it should never be assumed. A medication may affect appetite and body weight without being the right or approved option for a given patient in a weight loss program.

This is where online information gets messy. Consumers often see the ingredient name, hear about impressive outcomes, and assume every version of that medication serves the same purpose. In reality, indication, dose range, and prescribing criteria can differ. A physician-supervised program helps filter out that confusion and focus on what is medically appropriate.

How these medications differ in real life

On paper, it is easy to group these drugs together. In practice, the differences are meaningful. Dosing frequency is one factor. A once-weekly injection may be easier to maintain than a daily one, especially for people balancing work, travel, family, and other demands.

Side effects are another point of separation. Many GLP-1-based medications share gastrointestinal side effects, but the intensity and timing can vary from person to person. One patient may tolerate semaglutide well and struggle with another option. Someone else may need a slower titration plan or a change in medication because the appetite suppression feels too aggressive.

Then there is the question of outcomes. Some medications have produced greater average weight loss in clinical settings than others, but averages do not predict exactly what any one patient will experience. Lifestyle patterns, sleep, stress, insulin resistance, adherence, and dose progression all influence results. Medication is powerful, but it works best when it is part of a broader treatment strategy.

Who may be a candidate for GLP-1 therapy

GLP-1-based treatment is commonly considered for adults with obesity or for those who are overweight with weight-related health concerns. The details matter. A clinician typically looks at body mass index, metabolic history, current medications, personal and family history, and whether there are reasons a medication should be avoided.

These therapies are not cosmetic quick fixes. They are prescription medications that should be used with proper screening and follow-up. Certain patients may not be appropriate candidates based on medical history, pregnancy status, gastrointestinal conditions, or other risk factors. That is one reason a legitimate telehealth model should include evaluation, prescribing standards, and ongoing monitoring rather than simple checkout-page access.

For patients who do qualify, the appeal is clear. A structured, physician-supervised plan can offer medical credibility, convenience, and a treatment path that feels more sustainable than trying to white-knuckle hunger on another restrictive diet.

What to expect if you start treatment

Starting a GLP-1 medication usually involves more than receiving a prescription. Most patients begin at a lower dose and increase gradually over time. That titration process is designed to improve tolerability and reduce the likelihood of side effects. Patience matters early on.

Appetite often changes before the scale changes dramatically. Many patients notice they feel full faster, think about food less often, or find portion control easier. That can be encouraging, but treatment still works best when paired with adequate protein intake, hydration, movement, and a realistic nutrition plan.

It is also normal for progress to vary. Some patients respond quickly. Others lose weight more gradually. Plateaus can happen, and side effects may require dose adjustments or a change in strategy. The strongest programs account for those variables instead of promising the same timeline to everyone.

Why medical supervision matters

The popularity of GLP-1 therapy has created a lot of noise. The medication category is legitimate. The marketplace around it is not always as reliable. When consumers are comparing examples of GLP-1 drugs, the better question is often not just which drug is popular, but which care model is safe, personalized, and built for follow-through.

Physician supervision matters because screening matters. Monitoring matters. Knowing when to escalate, pause, or switch treatment matters. For people pursuing weight loss as part of a broader health upgrade, that level of care can make the experience more effective and more sustainable.

A modern telehealth platform like GOAL.MD can make that process feel more accessible – with clinical oversight, personalized treatment planning, and home delivery that fits into real life. Convenience is valuable, but only when it is paired with legitimate medical standards.

The most useful way to think about GLP-1 medications is not as a trend, but as a category of tools. The best tool is the one chosen carefully, prescribed responsibly, and supported by a plan you can actually stay with.

Medically reviewed by Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD. Physician-supervised telehealth. More at goal.md/blog.